The text discusses the flaws in a study by Mast et al. that analyzed RNA sequencing data from COVID-19 patients and controls. The study used samples from two different studies, one of which included samples from individuals with comorbidities labeled as "healthy controls." The study also compared samples with different library preparation methods and insufficient sequencing depth, leading to unreliable differential expression analysis. The study's conclusions, including the impact of SARS-CoV-2 on the coagulation cascade, were found to be inaccurate and contradicted by other research in the field. The text emphasizes the importance of rigorous quality control in research and the need for accurate data analysis to advance understanding of COVID-19.